Hudson Bay Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$769K	Sell	60,000 -255,000	-81%	-$3.25M	﹤0.01%	922
2025 Q4	$2.83M	Buy	315,000 +85,000	+37%	+$1.17M	0.02%	639
2025 Q3	$3.97M	Sell	230,000 -235,000	-51%	-$2.89M	0.02%	610
2025 Q2	$4.36M	Sell	465,000 -100,000	-18%	-$821K	0.03%	576
2025 Q1	$4.02M	Buy	565,000 +52,700	+10%	+$532K	0.03%	659
2024 Q4	$5.97M	Buy	512,300 +177,300	+53%	+$2.77M	0.04%	468
2024 Q3	$6.88M	Buy	335,000 +60,000	+22%	+$1.38M	0.05%	357
2024 Q2	$6.15M	Buy	275,000 +27,700	+11%	+$660K	0.05%	341
2024 Q1	$6.8M	Buy	247,300 +9,800	+4%	+$272K	0.06%	239
2023 Q4	$7.24M	Buy	237,500 +52,300	+28%	+$1.5M	0.06%	242
2023 Q3	$5.86M	Buy	185,200 +25,200	+16%	+$978K	0.06%	252
2023 Q2	$6.52M	Sell	160,000 -40,000	-20%	-$1.62M	0.07%	259
2023 Q1	$7.45M	Sell	200,000 -8,100	-4%	-$318K	0.08%	222
2022 Q4	$7.26M	Buy	208,100 +193,100	+1,287%	+$9.18M	0.08%	240
2022 Q3	$839K	Sell	15,000 -55,300	-79%	-$3.43M	0.01%	861
2022 Q2	$3.64M	Buy	70,300 +5,900	+9%	+$300K	0.04%	570
2022 Q1	$4.68M	Buy	64,400 +34,400	+115%	+$2.91M	0.07%	402
2021 Q4	$3.55M	Buy	30,000 +12,500	+71%	+$1.57M	0.04%	491
2021 Q3	$2.35M	Buy	+17,500	New	+$2.65M	0.03%	592